OxyNov receives first order of its FreeO2 oxygen therapy device from a French hospital
SOVAR would like to extend their warmest congratulations to the company OxyNov, which has just received a first order of its FreeO2 oxygen therapy device from the Pneumology Department of the CHU of Toulouse in France. This first order comes shortly after OxyNov’s leading product has met the CE marking requirements for commercialization in Europe.
OxyNov was founded in 2009, from research performed at Université Laval and the Institut Universitaire de Cardiologie et de Pneumologie de Québec, among others. For the past four years, SOVAR has been helping OxyNov with its development.
Read the release from CHU of Toulouse : http://www.chu-toulouse.fr/oxygenotherapie-le-chu-de-toulouse-se-dote-d-un
OxyNov : http://www.oxynov.com/
Gestion Sovar inc. :
Yves Matte, Director
418 650-2829, ext. 233 | email@example.com